Article info

Download PDFPDF

Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13
Free
  1. Correspondence to:
    Professor Guido Valesini, Dipartimento di Terapia Medica, Cattedra di Reumatologia, Viale del Policlinico 155, 00161, Roma, Italy;
    guido.valesini{at}uniroma1.it
View Full Text

Citation

Pittoni V, Bombardieri M, Spinelli FR, et al
Anti-tumour necrosis factor (TNF) α treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13

Publication history

  • Accepted February 4, 2002
  • First published August 1, 2002.
Online issue publication 
August 01, 2002

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.